| Promore Pharma AB (publ) Delårsrapport januari – september 2018 | Report (pdf) |
| Delårsrapport januari – juni 2018 | Report (pdf) |
| Promore Pharma AB (publ) Delårsrapport januari – mars 2018 | Report (pdf) |
| Årsredovisning 2017 | Report (pdf) |
| Bokslutskommuniké 2017 | Report (pdf) |
The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.
To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.
To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.